Back
Fidelity Disruptive Medicine ETF Vs. Tema Obesity & Cardiometabolic ETF Industry Stock Comparison
Sell
43
FMED
Fidelity Disruptive Medicine ETF
Last Price:
25.44
Seasonality Move:
18.25%
Sell
20
HRTS
Tema Obesity & Cardiometabolic ETF
Last Price:
31.80
Seasonality Move:
0%
Sell
43
Fidelity Disruptive Medicine ETF (FMED)
is a Sell
Is Fidelity Disruptive Medicine ETF a Buy, Sell or Hold?
- The current Fidelity Disruptive Medicine ETF [FMED] share price is $25.93. The Score for FMED is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- FMED is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Tema Obesity & Cardiometabolic ETF (HRTS)
is a Sell
Is Tema Obesity & Cardiometabolic ETF a Buy, Sell or Hold?
- The current Tema Obesity & Cardiometabolic ETF [HRTS] share price is $31.79. The Score for HRTS is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- HRTS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
FMED Stock Price Chart
What is Fidelity Disruptive Medicine ETF's stock price today?
-
The Fidelity Disruptive Medicine ETF share price today is $25.93
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FMED is experiencing buying pressure, which is a positive indicator for future bullish movement.
HRTS Stock Price Chart
What is Tema Obesity & Cardiometabolic ETF's stock price today?
-
The Tema Obesity & Cardiometabolic ETF share price today is $31.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HRTS is experiencing slight buying pressure.
FMED Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.16 | Sell |
| Relative Strength Index (14 RSI): | 54.28 | Buy |
| Chaikin Money Flow: | 6238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.25 - 26.21) | Buy |
| Bollinger Bands (100): | (24.89 - 26.19) | Buy |
HRTS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 43.4 | Sell |
| Chaikin Money Flow: | 2 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.49 - 33.83) | Sell |
| Bollinger Bands (100): | (32.7 - 34.9) | Sell |
FMED Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 25.19 | Buy |
| 20-day SMA: | 25.68 | Buy |
| 50-day SMA: | 25.9 | Buy |
| 200-day SMA: | 25 | Buy |
| 8-day EMA: | 25.46 | Buy |
| 20-day EMA: | 25.61 | Buy |
| 50-day EMA: | 25.71 | Buy |
| 200-day EMA: | 24.97 | Buy |
HRTS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.11 | Buy |
| 20-day SMA: | 32.44 | Sell |
| 50-day SMA: | 33.25 | Sell |
| 200-day SMA: | 33.27 | Sell |
| 8-day EMA: | 31.48 | Buy |
| 20-day EMA: | 32.18 | Sell |
| 50-day EMA: | 32.97 | Sell |
| 200-day EMA: | 32.72 | Sell |
Fidelity Disruptive Medicine ETF Earnings Growth & FMED Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tema Obesity & Cardiometabolic ETF Earnings Growth & HRTS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Fidelity Disruptive Medicine ETF Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Tema Obesity & Cardiometabolic ETF Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||